| | | 62492 | | 04.10.2012 | | Boehringer Ingelheim (Schweiz) GmbH | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Jentadueto 2.5 mg/500 mg | Filmtabletten | Coated tablets (Linagliptinum 2.5 mg, Metformin Hydrochloride 500 mg) | A10BD11 | CI | | 02 | Jentadueto 2.5 mg/850 mg | Filmtabletten | Coated tablets (Linagliptinum 2.5 mg, Metformin Hydrochloride 850 mg) | A10BD11 | CI | | 03 | Jentadueto 2.5 mg/1000 mg | Filmtabletten | Coated tablets (Linagliptinum 2.5 mg, Metformin Hydrochloride 1000 mg) | A10BD11 | CI |
|
|
